Australia markets open in 7 hours 44 minutes

Supernus Pharmaceuticals, Inc. (SUPN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
29.85-0.41 (-1.35%)
As of 12:13PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
607,521
607,521
667,238
579,775
520,397
Cost of revenue
83,779
83,779
87,221
75,061
52,459
Gross profit
523,742
523,742
580,017
504,714
467,938
Operating expenses
Research development
91,593
91,593
74,552
90,467
75,961
Selling general and administrative
336,361
336,361
377,221
304,759
200,677
Total operating expenses
510,339
510,339
534,403
425,215
292,340
Operating income or loss
13,403
13,403
45,614
79,499
175,598
Interest expense
2,415
2,415
7,070
23,423
23,754
Total other income/expenses net
-18,672
-18,672
510
6,530
-1,900
Income before tax
2,769
2,769
60,743
73,175
168,648
Income tax expense
1,453
1,453
32
19,751
41,698
Income from continuing operations
1,316
1,316
60,711
53,424
126,950
Net income
1,316
1,316
60,711
53,424
126,950
Net income available to common shareholders
1,316
1,316
60,711
53,424
126,950
Basic EPS
0.47
-
1.13
1.01
2.41
Diluted EPS
0.42
-
1.04
0.98
2.36
Basic average shares
54,401
-
53,665
53,099
52,615
Diluted average shares
57,204
-
61,680
54,357
53,690